SCHEDULE: Vanguard Adjusts Inspire Medical Systems Stake

Vanguard Portfolio Management has updated its Schedule 13G filing, reporting beneficial ownership of 6.02% of Inspire Medical Systems Inc. common stock as of September 30, 2026.

Summary

• Vanguard Portfolio Management, through its affiliates, has filed an amendment to its Schedule 13G, indicating a beneficial ownership stake of 6.02% in Inspire Medical Systems Inc.
• The filing, dated October 30, 2026, reflects the ownership as of September 30, 2026.
• The total number of shares beneficially owned is 1,741,113.
• Vanguard Portfolio Management has sole dispositive power over all 1,741,113 shares.
• Vanguard Portfolio Management has sole voting power over 36,509 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily reflecting routine portfolio management adjustments by a major institutional investor rather than company-specific performance news.

Positives

• Vanguard, a significant institutional investor, maintains a substantial ownership stake, suggesting continued confidence in the company's long-term prospects.
• The filing confirms Vanguard's active management of its portfolio, which can be seen as a sign of a healthy and dynamic investment landscape.

Negatives

• The filing does not provide any new operational or financial performance data for Inspire Medical Systems Inc., making it difficult to assess the company's current health.
• The specific reasons for the reported share ownership levels are not detailed, leaving room for speculation.

Risks

• The filing does not explicitly mention any new risks or changes to existing risk factors for Inspire Medical Systems Inc.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding Inspire Medical Systems Inc.'s future performance. It solely reports on Vanguard's current beneficial ownership.

Management Comments

• "In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Portfolio Management LLC and the following affiliates of Vanguard Portfolio Management LLC or business divisions of such affiliates: Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC."
• "This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Portfolio Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power."
• "This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Portfolio Management LLC, or business divisions of such subsidiaries whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release."
• "Vanguard Portfolio Management, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

StockSavvy.ai notes that this filing is a routine Schedule 13G amendment, typical for large institutional investors like Vanguard adjusting their holdings. It does not reflect company-specific news but rather the ongoing management of investment portfolios within the medical technology sector.

Stakeholder Impact

• Shareholders: The filing indicates a significant institutional investor's stake, which can influence market perception and trading dynamics, though no new information about the company's performance is provided.
• Creditors: No direct impact is indicated as the filing pertains to equity ownership.
• Employees: No direct impact is indicated as the filing pertains to equity ownership.

Next Steps

• Vanguard will continue to manage its investment in Inspire Medical Systems Inc. according to its investment strategies.
• Inspire Medical Systems Inc. will continue its business operations and disclosures as required.

Key Dates

Keywords

Vanguard, Inspire Medical Systems, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Portfolio Management